Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLST.L Regulatory News (CLST)

  • There is currently no data for CLST

ClearStar agreement with IntelliCentrics

28 Mar 2017 07:00

RNS Number : 6788A
ClearStar,Inc.
28 March 2017
 

 

ClearStar's Titer and Drug Screening Solution to be Integrated into IntelliCentrics' SEC3URE Program for Hospitals and Healthcare Organisations

 

ClearStar's automated order placement, registration, automatic transmission, to eliminate the traditional paper-intensive forms and inefficient way of collating data for titer and drug screening tests

 

ClearStar (AIM: CLSU and CLST), the technology and service provider to the background check industry, is pleased to announce that it has entered into a partnership with IntelliCentrics, the healthcare industry leader with over 10,000 distinct installations of vendor credentialing across the USA, Canada, and the United Kingdom.

 

Under the terms of the partnership, ClearStar's automated titer and drug screening solution will be integrated into IntelliCentrics' SEC³URE Program for Hospitals and Healthcare Organisations. The SEC³URE healthcare experience is designed to allow hospitals to control access by healthcare industry representatives (HIR), by ensuring only those that comply with the hospital's specific policies gain access to patient sensitive or restricted areas.

 

Individual hospitals decide entry requirements, which can include relevant immunisations, professional accreditations and compliance with hospital policies. A titer test measures the existence and levels of antibodies in the blood i.e. the ability to provoke a response from the immune system to disease. This response can come from natural exposure or from vaccination. Rather than hospital staff having to conduct the checks, HIRs pre-register via the SEC³URE system, which confirms their compliance status when they arrive on site.

 

With this partnership, IntelliCentrics has the tools for its members to streamline the titer and drug testing ordering and results, saving time and money. With automated order placement, registration, automatic transmission, it will eliminate the traditional paper-intensive titer and drug test forms, double data-entry, and multiple logins to the test ordering websites.

 

"Members of the IntelliCentrics community rely on us to deliver and provide the most efficient service and technology to do their jobs at peak levels while concurrently safeguarding a SEC3URE healthcare experience for everyone. Our affiliation with ClearStar advances our capability to protect our entire community," comments Mike Sheehan, Global CEO of IntelliCentrics. Sheehan continues "The partnership between IntelliCentrics and ClearStar is at the core of our belief that we all play a role in a safe and SEC3URE healthcare experience." 

 

"We are very proud to be working with IntelliCentrics with whom we share a common goal of assuring safety for the healthcare providers and patients through this new best-of-breed solution," stated Robert Vale, CEO of ClearStar. "By integrating our mobile, paperless chain of custody technology with IntelliCentrics' industry-leading service technology infrastructure, we will enable healthcare personnel to be screened and approved for work more quickly thereby meeting the aggressive time demands on the healthcare industry."

 

 

Enquiries

 

ClearStar, Inc.

Robert J. Vale, Chief Executive Officer

David Pattillo, Chief Financial Officer

+1 770 416 1900

finnCap Ltd.

Jonny Franklin-Adams, Simon Hicks - Corporate Finance

Christian Hobart, Abigail Wayne - Corporate Broking

+44 20 7220 0500

Luther Pendragon Ltd.

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

Notes to Editors

 

About ClearStar

 

ClearStar, Inc. is a leading and trusted background check technology, strategic services, and decision-making information provider to employers and background screening companies.

 

A seven-time Inc. 5000 honouree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

 

About IntelliCentrics

 

IntelliCentrics, the security experts, is in the business of savings lives by creating a safe and SEC³URE healthcare experience. IntelliCentrics is uniquely qualified to help hospitals and healthcare organizations to provide high-quality patient care. By prioritizing security, IntelliCentrics facilities meet or exceed compliance best practices by letting everyone in safely. More healthcare facilities across seven countries adopt IntelliCentrics standards than all competitors combined. Now, every person entering a facility can contribute to preserving patient care, from physicians to patient visitors, vendors, volunteers, and staff. To learn more about IntelliCentrics, the leading provider of managed services to maintain compliance programs to create a safe and SEC³URE healthcare experience, please phone (817) SEC³URE or visit www.IntelliCentrics.com.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLLFEAVEIDFID
12
Date   Source Headline
4th Sep 201712:00 pmRNSAmalgamation of Stock Lines and TVR
14th Jul 201711:12 amRNSHolding(s) in Company
13th Jul 20175:35 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSTrading Update
8th Jun 201712:38 pmRNSDirector/PDMR Shareholding
2nd Jun 20171:21 pmRNSDirector/PDMR Shareholding
26th May 20175:21 pmRNSHolding(s) in Company
25th May 20177:00 amRNSPDMR Shareholding
23rd May 20176:24 pmRNSResult of AGM
15th May 20173:39 pmRNSPDMR Shareholding
9th May 20173:28 pmRNSHolding(s) in Company
4th May 20177:00 amRNSClearStar agreement with MultiLatin
26th Apr 20177:00 amRNSNotice of AGM and Posting of Annual Report
20th Apr 20172:28 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSPDMR Shareholding
12th Apr 20177:00 amRNSPDMR Shareholding
4th Apr 20177:00 amRNSPDMR Shareholding
31st Mar 20177:00 amRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFull Year Results
28th Mar 20177:00 amRNSClearStar agreement with IntelliCentrics
26th Jan 20177:00 amRNSTrading Update
1st Nov 20167:00 amRNSDirector/PDMR Shareholding
27th Sep 20167:01 amRNSInterim Results
27th Sep 20167:00 amRNSChange of Adviser
24th May 20166:16 pmRNSResult of AGM
24th May 20167:00 amRNSAGM Statement
29th Apr 20165:21 pmRNSNotice of AGM and Posting of Annual Report
22nd Mar 20167:00 amRNSPreliminary Results
5th Jan 20167:00 amRNSGrant of Options
14th Dec 20155:07 pmRNSDirector/PDMR Shareholding
3rd Dec 20154:14 pmRNSRule 17 Notification
19th Nov 20157:00 amRNSLargest Direct Services contract win to date
12th Oct 20157:00 amRNSBusiness and Trading Update
22nd Sep 20157:00 amRNSInterim Results
3rd Sep 20157:00 amRNSNotice of Interim Results
28th Aug 20157:00 amRNSRestricted ordinary shares to be traded in CREST
23rd Jul 20151:24 pmRNSTrading Statement
13th Jul 20154:35 pmRNSClearStar Shares to be traded on CREST
4th Jun 20154:01 pmRNSHolding(s) in Company
29th May 20157:00 amRNSDirector Share Purchase
19th May 20154:33 pmRNSResult of AGM
23rd Apr 20155:30 pmRNSNotice of AGM and Posting of Annual Report
8th Apr 20157:00 amRNSClearStar expedites Drug Screening Process
16th Mar 20157:00 amRNSPreliminary Results
2nd Feb 20157:00 amRNSSignificant drug screening contract win
21st Jan 20157:00 amRNSTrading Update
17th Dec 20147:00 amRNSAcquisition of SingleSource Services Corporation
17th Nov 20147:00 amRNSContract win
8th Sep 20147:00 amRNSInterim Results for Six Months Ended 30 June 2014
28th Jul 20147:00 amRNSAppointment of Nicolas Dufour as General Counsel
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.